Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
INCYTE CORP | Director | Common Stock | 19.4K | $1.28M | $66.10 | Sep 30, 2024 | Direct |
EXACT SCIENCES CORP | Director | Common Stock | 20.6K | $1.06M | $51.35 | Jun 13, 2024 | Direct |
AGIOS PHARMACEUTICALS, INC. | Director | Restricted stock unit | 4.98K | $123K | $24.79 | Jun 21, 2022 | Direct |
AGIOS PHARMACEUTICALS, INC. | Director | Stock options (right to buy) | 29.3K | Jun 21, 2022 | Direct | ||
Xilio Therapeutics, Inc. | Director | Stock Option (right to buy) | 25K | Jun 14, 2024 | Direct | ||
INCYTE CORP | Director | Non Qualfied Stock Option (right to buy) | 12.5K | Jun 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
INCY | INCYTE CORP | Sep 30, 2024 | 1 | $24.3K | 4 | Oct 2, 2024 | Director |
INCY | INCYTE CORP | Jun 28, 2024 | 1 | $24.2K | 4 | Jul 2, 2024 | Director |
XLO | Xilio Therapeutics, Inc. | Jun 14, 2024 | 1 | $0 | 4 | Jun 17, 2024 | Director |
EXAS | EXACT SCIENCES CORP | Jun 13, 2024 | 1 | $0 | 4/A | Dec 20, 2024 | Director |
INCY | INCYTE CORP | Jun 12, 2024 | 2 | $0 | 4 | Jun 14, 2024 | Director |
INCY | INCYTE CORP | Mar 28, 2024 | 1 | $23K | 4 | Apr 2, 2024 | Director |
INCY | INCYTE CORP | Dec 29, 2023 | 1 | $25.9K | 4 | Jan 3, 2024 | Director |
INCY | INCYTE CORP | Sep 29, 2023 | 1 | $21.9K | 4 | Oct 3, 2023 | Director |
INCY | INCYTE CORP | Jun 30, 2023 | 1 | $23.7K | 4 | Jul 5, 2023 | Director |
INCY | INCYTE CORP | Jun 14, 2023 | 2 | $0 | 4 | Jun 16, 2023 | Director |
XLO | Xilio Therapeutics, Inc. | Jun 12, 2023 | 1 | $0 | 4 | Jun 13, 2023 | Director |
EXAS | EXACT SCIENCES CORP | Jun 8, 2023 | 1 | $0 | 4 | Jun 12, 2023 | Director |
INCY | INCYTE CORP | Mar 31, 2023 | 1 | $23K | 4 | Apr 4, 2023 | Director |
INCY | INCYTE CORP | Dec 30, 2022 | 1 | $23.6K | 4 | Jan 4, 2023 | Director |
INCY | INCYTE CORP | Sep 30, 2022 | 1 | $22.6K | 4 | Oct 4, 2022 | Director |
INCY | INCYTE CORP | Jun 30, 2022 | 1 | $24.4K | 4 | Jul 1, 2022 | Director |
AGIO | AGIOS PHARMACEUTICALS, INC. | Jun 21, 2022 | 2 | $0 | 4 | Jun 23, 2022 | Director |
XLO | Xilio Therapeutics, Inc. | Jun 15, 2022 | 1 | $0 | 4 | Jun 17, 2022 | Director |
INCY | INCYTE CORP | Jun 15, 2022 | 2 | $0 | 4 | Jun 17, 2022 | Director |
EXAS | EXACT SCIENCES CORP | Jun 9, 2022 | 1 | $0 | 4 | Jun 13, 2022 | Director |
AGIO | AGIOS PHARMACEUTICALS, INC. | May 20, 2022 | 2 | $0 | 4 | May 24, 2022 | Director |
INCY | INCYTE CORP | Mar 31, 2022 | 1 | $25.9K | 4 | Apr 4, 2022 | Director |
INCY | INCYTE CORP | Dec 31, 2021 | 1 | $25.2K | 4 | Jan 4, 2022 | Director |
XLO | Xilio Therapeutics, Inc. | Oct 26, 2021 | 2 | $0 | 4 | Oct 26, 2021 | Director |
XLO | Xilio Therapeutics, Inc. | Oct 21, 2021 | 0 | $0 | 3 | Oct 21, 2021 | Director |
INCY | INCYTE CORP | Sep 30, 2021 | 1 | $22.1K | 4 | Oct 4, 2021 | Director |
EXAS | EXACT SCIENCES CORP | Jun 30, 2021 | 1 | $0 | 4 | Jul 2, 2021 | Director |
INCY | INCYTE CORP | Jun 30, 2021 | 1 | $23.8K | 4 | Jul 2, 2021 | Director |
AGIO | AGIOS PHARMACEUTICALS, INC. | May 28, 2021 | 2 | $0 | 4 | Jun 2, 2021 | Director |
INCY | INCYTE CORP | May 26, 2021 | 2 | $0 | 4 | May 28, 2021 | Director |
AGIO | AGIOS PHARMACEUTICALS, INC. | May 20, 2021 | 2 | $0 | 4 | May 24, 2021 | Director |